Abstract Based on current efficacy evaluation of Chinese medicine treatment of hypothyroidism, we explore the feasibility of introducing PRO (Patient Reported Outcomes) as the clinical evaluation index. Learning from the experience of PRO checklist evaluation method of Western medicine, we can develop the hypothyroidism PRO scale of Chinese medicine, to make the efficacy evaluation more quantitative and objective.